Justin B. Klee sold $933K of Amylyx Pharmaceuticals (AMLX)

Executed Sep 10, disclosed Sep 14, 4 days later.

Value, as filed

$933K

29,025 sh × $32.13

Executed

Sep 10

the trade date, as filed

Disclosed

Sep 14

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Justin B. Klee Co-Chief Executive Officer profile →

Justin B. Klee (Co-Chief Executive Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Amylyx Pharmaceuticals, Inc. (AMLX). The largest single filing was $1.8M of AMLX (136,193 sh × $13.58, as filed), executed Jan 15.

The name

AMLX

Amylyx Pharmaceuticals, Inc. AMLX · Healthcare · 20 filings in 24 months ticker →

Healthcare · Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for ne…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Justin B. Klee in AMLX

AMLXSALE Amylyx Pharmaceuticals, Inc. $424K
29,282 sh × $14.47
Exec Mar 2
Filed Mar 4 · 5:30 PM ET AMLXSALE Amylyx Pharmaceuticals, Inc. $228K
15,500 sh × $14.69
Exec Feb 2
Filed Feb 4 · 5:30 PM ET AMLXSALE Amylyx Pharmaceuticals, Inc. $1.8M
136,193 sh × $13.58
Exec Jan 15
Filed Jan 20 · 5:30 PM ET AMLXSALE Amylyx Pharmaceuticals, Inc. $428K
29,775 sh × $14.37
Exec Sep 30 2025
Filed Oct 2 2025 · 5:30 PM ET